Neurosensorial Disorder and Pain in Oral Cavity and Oropharynx Cancer Traited Patients (OCAPA)
NCT04673981
Summary
Following preliminary studies carried out in our department on these subject and subjective findings during clinical examinations, it has been shown that pain is a symptom that is rarely reported following treatment. Instead, neurosensory disorders such as hypoesthesia and paresthesia are found. The objective of the study is to map and qualitatively evaluate neurosensory disorders in patients treated for cancers of the oral cavity and oropharynx.
Eligibility
Inclusion Criteria: * Patient treated for an oral cavity and oropharynx tumor from at least one year and maximum five years. * Women or men upper 18 years old) * Patient with full consent, aware and signed * Patient cover by the French social security system Exclusion Criteria: * Patient with mental disorder, psychologic, with a defect of comprehension to agree fully the protocol * Pregnant women or nursing * Patients who can't comply with the protocol * Participation refusal * Inable full age patient or under judicial protection
Conditions4
Browse More Trials
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.
NCT04673981